| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df874e3cf88adba3792dc9d5b5776180 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
1988-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3784c6f61a72ba87fc56a31d0f0319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecae6a1027d61a7b4523b5e31ae9f2b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae15f7bb0178032601e06b9e8187bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feec1ee8093d13889b04305785550f51 |
| publicationDate |
1989-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0309532-A1 |
| titleOfInvention |
Phamaceutical composition, for oral administration, designed to attenuate the effects of -lactamines |
| abstract |
The subject of the present invention is a pharmaceutical composition, which can be administered orally, intended to reduce the effects of ss-lactams on the intestinal flora in humans, and characterized in that it comprises strict anaerobic bacteria which are not pathogenic for man and producers of ss-lactamases. |
| priorityDate |
1987-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |